Trademark: 98298155
Word
ECHO
Status
Pending
Status Code
661
Status Date
Thursday, June 20, 2024
Serial Number
98298155
Mark Type
4
Filing Date
Monday, December 4, 2023

Trademark Owner History

Classifications
40 Custom manufacturing of cell culture and cell therapy systems, apparatus and equipment for others; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies, including using cell lines, iPS (induced pluripotent stem) cells, genetically modified iPS cells or differentiated cells derived therefrom, for others; custom manufacture of cellular therapies; information, advice and consultancy in relation to all the aforesaid.
42 Platform as a service (PaaS) featuring computer software platforms for developing cell therapies; providing temporary use of web-based software platforms for developing and characterizing cell lines; providing temporary use of non-downloadable computer software platforms for developing and manufacturing cell-based therapies and analyzing data for purposes of process optimization and quality control; laboratory research in the field of biotechnology in general and in particular using cell lines, iPS (induced pluripotent stem) cells, genetically modified iPS cells or differentiated cells derived therefrom; scientific research, design and technological development services in the field of biotechnology, for the pharmaceutical and medical industry; scientific research, design, testing and technological development of cell cultures, cell-based products, genetically modified cell products, cell therapies, and gene-edited cell therapy systems, equipment and apparatus; scientific research, design and development of systems and processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; calibration of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data

Trademark Events
Dec 4, 2023
New Application Entered
Feb 28, 2024
New Application Office Supplied Data Entered
Mar 19, 2024
Assigned To Examiner
Mar 23, 2024
Non-Final Action Written
Mar 23, 2024
Non-Final Action E-Mailed
Mar 23, 2024
Notification Of Non-Final Action E-Mailed
Jun 20, 2024
Correspondence Received In Law Office
Jun 20, 2024
Teas/Email Correspondence Entered
Jun 20, 2024
Teas Response To Office Action Received

Trademark Alertz updated from USPTO on 2030-01-24